Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IOC 2027

Eye Tumors at IOC 2027

Part of the IOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Eye Tumors Session

Eye tumors in ophthalmology encompass a spectrum of conditions, ranging from benign growths to malignant cancers. These tumors can affect various parts of the eye, including the eyelids, conjunctiva, iris, choroid, retina, and optic nerve. Symptoms may vary depending on the location and type of tumor but can include changes in vision, eye pain, bulging of the eye, and in some cases, visible growths on the surface of the eye.

Diagnosis typically involves a comprehensive eye examination, imaging studies such as ultrasound or MRI, and sometimes a biopsy for definitive identification. Treatment options vary widely and depend on factors like the type of tumor, its location, and whether it is benign or malignant. Treatments may include observation, surgical removal, radiation therapy, chemotherapy, or a combination of these approaches. Early detection and prompt management are crucial in preserving vision and preventing potential spread or complications associated with malignant tumors.

Topics Covered in Eye Tumors

Topic 01

Eyelid Basal Cell Carcinoma

Topic 02

Conjunctival Tumors

Topic 03

Choroidal Nevus & Melanoma

Topic 04

Choroidal Hemangioma

Topic 05

Optic Nerve Sheath Meningioma

Topic 06

Plaque Brachytherapy

Related Scientific Sessions at IOC 2027

Why Attend the Eye Tumors Conference 2027

Earn CPD Credit

Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.

Present Your Research

Oral and poster slots for original Eye Tumors work, reviewed by the scientific committee.

Network Globally

Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.

Publish & Get Indexed

Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.

Learn from Keynotes

Plenary lectures from leading voices shaping Eye Tumors research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IOC 2027 for the Eye Tumors track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Eye Tumors Conference 2027 — FAQs

What is the Eye Tumors track at IOC 2027?

The Eye Tumors track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Eye Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Eye Tumors sessions?

Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Eye Tumors are all welcome — whether presenting or attending.

Can I present my research in the Eye Tumors track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Eye Tumors sessions?

Yes. IOC 2027 is a hybrid conference — attend the Eye Tumors track in person in Singapore or join live online, with on-demand access afterward.

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us